Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/22/10 → 9/30/11 |
Funding
- Cytokinetics Incorporated: $17,341.00
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients with Amyotrophic Lateral Sclerosis (ALS)
- Kasarskis, Edward (PI)